investor harm

Class action lawsuit filed against NuScale Power alleging securities fraud over misrepresented partner ENTRA1's nuclear experience, impacting commercialization strategy.

Class action lawsuit filed against $PYPL alleging executives made false statements about revenue projections and 2027 targets. Lead plaintiff deadline set for April 20, 2026.

Class action lawsuit filed against $AQST alleging misleading statements about FDA approval timeline for Anaphylm and concealed human factors risks.

Class action lawsuit filed against $ENPH alleges company overstated inventory management capabilities and minimized 25D tax credit termination impact during April-October 2025 period.

Class action filed against Camping World Holdings alleging material false statements on inventory management and consumer demand forecasts during April 2025-February 2026 period; lead plaintiff deadline May 11, 2026.

Law firm files class action against Beyond Meat for allegedly misleading investors about asset values and SEC filing delays from February-November 2025.

Class action lawsuit filed against $PLUG alleging false statements about DOE funding and hydrogen facilities between January-November 2025. Investors have until April 3, 2026 to join.

Class action lawsuit filed against monday.com alleging false revenue and growth statements from September 2025 to February 2026. Investors urged to participate in suit.

Class action lawsuit filed against $EOSE alleging securities fraud over undisclosed production delays, battery quality issues, and false guidance during November 2025-February 2026 period.

Class action filed against $AMC alleging securities fraud over APE preferred equity units being excluded from special dividend after conversion to common stock.

Trip.com faces class action alleging false statements about regulatory risks tied to monopolistic practices, covering investors from April 2024 to January 2026.

Class action lawsuit filed against Snowflake alleging executives misled investors about product efficiency improvements and pricing changes while concealing CEO resignation plans.

Class action lawsuit filed against Mereo BioPharma over alleged misstatements regarding failed Phase 3 clinical trials. Investors have until April 6, 2026, to join.

Lawsuit filed against Driven Brands for securities fraud, alleging material misstatements, failed accounting controls, and overstated revenue spanning 2023-2024.

Class action lawsuit filed against $CORP alleging executives made false statements about relacorilant's clinical strength and FDA approval prospects.

Class action lawsuit filed against $METC alleges executives made false statements about Brook Mine development progress. Investors from July-October 2025 urged to participate.

Class action lawsuit filed against $NKTX alleging executives made false statements about REZOLVE-AA trial enrollment protocols, potentially harming investor value.

Smart Digital Group faces class action lawsuit alleging market manipulation, insider trading, and fraudulent social media promotion. Lead plaintiff deadline March 16, 2026.

Class action lawsuit filed against $TCOM alleging false statements on regulatory risks from monopolistic practices. Lead plaintiff deadline: May 11, 2026.

Class action lawsuit filed against Inovio Pharmaceuticals for allegedly making false statements about CELLECTRA device manufacturing and INO-3107 FDA submission timeline between October 2023 and December 2025.